News
The growing body of research on cannabigerol (CBG) reveals its immense potential as a therapeutic compound. With its anti-inflammatory, neuroprotective, antimicrobial, anticancer, and mood-stabilizing properties, CBG presents a promising avenue for the development of novel treatments for a wide range of health conditions.
Today’s blog will focus on the endocannabinoid system and its mechanism as a bridge between the bacteria and the body itself – especially in the relay to communication with the brain – a subject that has received a distinct lack of attention outside of scientific journals.
As in any system, imbalance causes problems. Humans need a steady stream of bacteria to maintain a healthy gut microbiome, these bacteria help break down the foods we eat and allow nutrients to be readily absorbed in the digestive tract. Other mitigating factors that influence the microbiome are exercise, diet, pharmaceuticals, and the consumption of cannabis or hemp.
We will let you guess which of these factors will result in a healthy gut biome vs. one considered imbalanced, or impaired.
